Rachel Schneerson
For the development of the Hemophilus influenza type b vaccine, a polysaccharide-conjugate vaccine that has all but eliminated childhood meningitis.
Affiliated at time of winning
Bethesda, United States
Recognition for work with lasting impact
For the development of the Hemophilus influenza type b vaccine, a polysaccharide-conjugate vaccine that has all but eliminated childhood meningitis.
Bethesda, United States